Last reviewed · How we verify
Investigating Genetic Risk for Type 1 Diabetes (INGR1D)
The objective of this study is to determine the percentage of children with genetic markers putting them at increased risk of developing type 1 diabetes, and to offer the opportunity for these children to be enrolled into a phase II b primary prevention trial.
Details
| Lead sponsor | University of Oxford |
|---|---|
| Status | COMPLETED |
| Enrolment | 15640 |
| Start date | Wed Apr 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Diabetes Mellitus, Type 1
- Diabetes Mellitus
- Glucose Metabolism Disorders
- Metabolic Disease
- Endocrine System Diseases
- Autoimmune Diseases
- Immune System Diseases
Countries
United Kingdom